DrugPatentWatch Database Preview

Ariad Company Profile

« Back to Dashboard

What is the competitive landscape for ARIAD, and when can generic versions of ARIAD drugs launch?

ARIAD has two approved drugs.

There are six US patents protecting ARIAD drugs.

There are eighty-seven patent family members on ARIAD drugs in twenty-one countries and fourteen supplementary protection certificates in twelve countries.

Summary for Ariad

International Patents:	87
US Patents:	6
Tradenames:	2
Ingredients:	2
NDAs:	2
Patent Litigation for Ariad:	See patent lawsuits for Ariad

Drugs and US Patents for Ariad

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ariad	ICLUSIG	ponatinib hydrochloride	TABLET;ORAL	203469-003	Apr 23, 2015		RX	Yes	No	9,493,470		Y	Y
Ariad	ALUNBRIG	brigatinib	TABLET;ORAL	208772-001	Apr 28, 2017		RX	Yes	No	9,012,462			Y
Ariad	ICLUSIG	ponatinib hydrochloride	TABLET;ORAL	203469-002	Dec 14, 2012		RX	Yes	Yes	8,114,874		Y	Y
Ariad	ALUNBRIG	brigatinib	TABLET;ORAL	208772-003	Oct 2, 2017		RX	Yes	No

Non-Orange Book US Patents for Ariad

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,470,851	Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors
8,278,307	Monocyclic Heteroaryl compounds
9,278,971	Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors
9,090,561	Acetylenic heteroaryl compounds

International Patents for Ariad Drugs

Country	Document Number	Estimated Expiration
Eurasian Patent Organization	200870116
Cyprus	1113907
Japan	2009536652
Portugal	1973545

Supplementary Protection Certificates for Ariad Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2013027	Lithuania		PRODUCT NAME: PONATINIBUM; REGISTRATION NO/DATE: EU/1/13/839/001, 2013 07 01 EU/1/13/839/002, 2013 07 01 EU/1/13/839/003, 2013 07 01 EU/1/13/839/004 20130701
0	Finland
00631	Netherlands		PRODUCT NAME: PONATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, SOLVAAT OF HYDRAAT; REGISTRATION NO/DATE: EU/1/13/839/001-004 20130701
327	Luxembourg		PRODUCT NAME: PONATINIB SOUS TOUTES SES FORMES TELLES QUE PROTEGEES PAR LE BREVET DE BASE

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Ariad